Effect of Licorice in treatment of Nonalcoholic Fatty Liver Disease

Phase 3

• Conditions: onalcoholic fatty liver disease.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT20200903048603N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Lack of acute or chronic Liver disease
Lack of using of Tabacco or alcohol
Lack of cardiovascular diseases, and Hypertension
Lack of Diabetes Mellitus, Kidney diseases, Malignancy, Viral Hepatitis, Wilson disease Hemochromatosis, Cystic fibrosis and Autoimmune diseases
Lack of using of any approved therapies known to have potential benefit in NAFLD control within the previous 3 months
Lack of using of Hepatotoxic drugs within the past 6 months

Exclusion Criteria

Lack of Fatty Liver in Ultrasonography

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
iver steatosis. Timepoint: Previous of intervention and 3 months after of initiating of study. Method of measurement: Ultrasonography.